Compute Healthcquisition Corp. Class A (CPUH) Financials
$10.36
As on 01-Aug-2023 19:00EDT
Market cap
$319 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.3
Div. Yield
0 %
Income Statement ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cost of Revenue
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Gross Profit
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Operating Expenses
|
6.53
|
4.69
|
2.23
|
--
|
--
|
--
|
|||||
|
Operating Profit (EBIT)
|
-6.53
|
-4.69
|
-2.23
|
-0.01
|
--
|
--
|
|||||
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
24.28
|
34.54
|
5.76
|
-0.01
|
--
|
--
|
|||||
|
Provision for Tax
|
2.17
|
2.17
|
-7.99
|
--
|
--
|
--
|
|||||
|
Profit after Tax (Net Income)
|
20.97
|
32.37
|
5.76
|
-0.01
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
18.22
|
--
|
5.76
|
-0.02
|
--
|
--
|
Liabilities ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
86.13
|
86.13
|
800.98
|
0.02
|
--
|
--
|
|||||
|
Minority Interest
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
7.83
|
7.83
|
62.81
|
0.29
|
--
|
--
|
|||||
|
Current Liabilities
|
1.38
|
1.38
|
0.37
|
0.31
|
--
|
--
|
|||||
|
Total Liabilities
|
96.72
|
95.34
|
864.16
|
0.33
|
--
|
--
|
Assets ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
94.33
|
94.33
|
862.55
|
0.28
|
--
|
--
|
|||||
|
Current Assets
|
1.01
|
1.01
|
1.61
|
0.05
|
--
|
--
|
|||||
|
Total Assets
|
99.16
|
95.34
|
864.16
|
0.33
|
--
|
--
|
|||||
|
Total Debt*
|
0.93
|
0.93
|
1.39
|
0.17
|
--
|
--
|
|||||
|
Net Current Assets
|
-2.80
|
-0.36
|
1.24
|
-0.26
|
--
|
--
|
Cashflow ($ Mln) |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
-3.16
|
-2.08
|
0.00
|
--
|
--
|
|||||
|
Cash Flow from Investing Activities
|
--
|
--
|
-862.50
|
-862.50
|
--
|
--
|
|||||
|
Cash from Financing Activities
|
--
|
-775.79
|
865.37
|
0.19
|
--
|
--
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
--
|
Financials Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash EPS ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Adjusted Book Value ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Free Cash Flow per Share ($)
|
--
|
--
|
--
|
--
|
--
|
--
|
Profitability Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
7.28
|
1.44
|
--
|
--
|
--
|
|||||
|
ROE (%)
|
4.57
|
7.30
|
1.44
|
--
|
--
|
--
|
|||||
|
ROA (%)
|
4.36
|
6.75
|
1.33
|
--
|
--
|
--
|
|||||
|
EBIT Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Net Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Growth Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EBIT Growth (%)
|
52.49
|
-110.09
|
-10,691.79
|
--
|
--
|
--
|
|||||
|
Net Profit Growth (%)
|
-57.10
|
461.74
|
111,563.17
|
--
|
--
|
--
|
|||||
|
EPS Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Book Value Growth (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
Valuation Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
1.30
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
-370.78
|
0.00
|
-0.05
|
--
|
--
|
--
|
|||||
|
Close Price ($)
|
7.21
|
7.11
|
6.85
|
--
|
--
|
--
|
|||||
|
High Price ($)
|
7.35
|
7.11
|
7.53
|
--
|
--
|
--
|
|||||
|
Low Price ($)
|
6.87
|
6.81
|
6.69
|
--
|
--
|
--
|
|||||
|
Market Cap ($ Cr)
|
318.63
|
--
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
--
|
0.01
|
0.00
|
8.57
|
--
|
--
|
|||||
|
Short term debt to equity ratio
|
0.01
|
0.01
|
--
|
8.57
|
--
|
--
|
|||||
|
Current Ratio
|
0.74
|
0.74
|
4.34
|
0.15
|
--
|
--
|
|||||
|
Quick Ratio
|
0.86
|
0.86
|
--
|
--
|
--
|
--
|
|||||
|
Interest Coverage
|
1.94
|
-0.12
|
-0.28
|
--
|
--
|
--
|
Operating Efficiency Ratios |
TTM | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 | Dec-15 | Dec-14 | Dec-13 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Asset Turnover
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Receivable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Inventory Days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Payable days
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Conversion Cycle
|
--
|
--
|
--
|
--
|
--
|
--
|